Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis

Brain Research

Volumn 1296, Issue , 2009, Pages 216-224

  Ohnishi, Shizuo ^a   Ito, Hidefumi ^a   Suzuki, Yasuhiro ^a   Adachi, Yasushi ^a   Wate, Reika ^a   Zhang, Jianhua ^a   Nakano, Satoshi ^a   Kusaka, Hirofumi ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); G93A mutant SOD1 transgenic mouse (mSOD1 Tg mouse); Intra bone marrow bone marrow transplantation (IBM BMT); Microglia

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; ENHANCED GREEN FLUORESCENT PROTEIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; MALE; MICROGLIA; MOTONEURON; MOUSE; NERVE CELL; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RADIATION; SPINAL CORD VENTRAL HORN; SURVIVAL; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BONE AND BONES; BONE MARROW TRANSPLANTATION; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION, MISSENSE; NEURONS; RANDOM ALLOCATION; SPINAL CORD; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 70349265930     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.08.012     Document Type: Article

References (48)

1. Appel, S.H., Smith, R.G., Engelhardt, J.I., Stefani, E., 1996. Autoimmunity and ALS. Neurology 47 Suppl 2: S40-46.
2. Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., and Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 103 (2006) 16021-16026
3. Beers D.R., Henkel J.S., Zhao W., Wang J., and Appel S.H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. USA 105 (2008) 15558-15563
4. Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol. Dis. 26 (2007) 1-13
5. Boillée S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., and Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
6. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
7. Chen R., and Ende N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J. Med. 31 (2000) 21-30
8. Chopp M., Zhang X.H., Li Y., Wang L., Chen J., Lu D., Lu M., and Rosenblum M. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. NeuroReport 11 (2000) 3001-3005
9. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillée S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.P., Goldstein L.S., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
10. Corti S., Locatelli F., Donadoni C., Guglieri M., Papadimitriou D., Strazzer S., Del Bo R., and Comi G.P. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 127 (2004) 2518-2532
11. Corti S., Locatelli F., Papadimitriou D., Del Bo R., Nizzardo M., Nardini M., Donadoni C., Salani S., Fortunato F., Strazzer S., Bresolin N., and Comi G.P. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 130 (2007) 1289-1305
12. Cui Y.Z., Hisha H., Yang G.X., Fan T.X., Jin T., Li Q., Lian Z., and Ikehara S. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant. 30 (2002) 843-849
13. Ende N., Weinstein F., Chen R., and Ende M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci. 67 (2000) 53-59
14. Garbuzova-Davis S., Willing A.E., Milliken M., Saporta S., Sowerby B., Cahill D.W., and Sanberg P.R. Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2 (2001) 175-180
15. Garbuzova-Davis S., Willing A.E., Milliken M., Saporta S., Zigova T., Cahill D.W., and Sanberg P.R. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp. Neurol. 174 (2002) 169-180
16. Garbuzova-Davis S., Willing A.E., Zigova T., Saporta S., Justen E.B., Lane J.C., Hudson J.E., Chen N., Davis C.D., and Sanberg P.R. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J. Hematother. Stem Cell Res. 12 (2003) 255-270
17. Garbuzova-Davis S., Willing A.E., Saporta S., Justen E.B., Misiuta I.E., Dellis J., and Sanberg P.R. Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 7 (2006) 221-226
18. Gowing G., Philips T., Van Wijmeersch B., Audet J.N., Dewil M., Van Den Bosch L., Billiau A.D., Robberecht W., and Julien J.P. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J. Neurosci. 28 (2008) 10234-10244
19. Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., and Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20 (2000) 660-665
20. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W., Zhai P., Sufit R.L., and Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
21. Habisch H.J., Janowski M., Binder D., Kuzma-Kozakiewicz M., Widmann A., Habich A., Schwalenstöcker B., Hermann A., Brenner R., Lukomska B., Domanska-Janik K., Ludolph A.C., and Storch A. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J. Neural Transm. 114 (2007) 1395-1406
22. Hayashi H., Toki J., Lian Z., Inoue K., and Ikehara S. Analyses of extrathymic T cell differentiation in nu/nu mice by grafting embryonal organs. Immunobiology 197 (1997) 1-15
23. Heiman-Patterson T.D., Deitch J.S., Blankenhorn E.P., Erwin K.L., Perreault M.J., Alexander B.K., Byers N., Toman I., and Alexander G.M. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J. Neurol. Sci. 236 (2005) 1-7
24. Hermann A., Gastl R., Liebau S., Popa M.O., Fiedler J., Boehm B.O., Maisel M., Lerche H., Schwarz J., Brenner R., and Storch A. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J. Cell Sci. 117 (2004) 4411-4422
25. Ikehara S. Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment. Int. J. Mol. Med. 1 (1998) 5-16
26. Ikehara S. New strategies for BMT and organ transplantation. Int. J. Hematol. 76 Suppl 1 (2002) 161-164
27. Ikehara S. A novel strategy for allogeneic stem cell transplantation: perfusion method plus intra-bone marrow injection of stem cells. Exp. Hematol. 31 (2003) 1142-1146
28. Ikehara S., Inaba M., Yasumizu R., Nagata N., Toki J., Hisha H., Sugiura K., Oyaizu N., Kawamura M., Than S., Takao F., Adachi Y., Nishimura M., Nishioka N., Mizutani H., Kurata Y., and Good R.A. Autoimmune diseases as stem cell disorders. Tohoku J. Exp. Med. 173 (1994) 141-155
29. Kang J., and Rivest S. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J. Cell Biol. 179 (2007) 1219-1230
30. Keene C.D., Sonnen J.A., Swanson P.D., Kopyov O., Leverenz J.B., Bird T.D., and Montine T.J. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology 68 (2007) 2093-2098
31. Kim M., Lee S.T., Chu K., and Kim S.U. Stem cell-based cell therapy for Huntington disease. Neuropathology 28 (2008) 1-9
32. Klein S.M., Behrstock S., McHugh J., Hoffmann K., Wallace K., Suzuki M., Aebischer P., and Svendsen C.N. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum. Gene Ther. 16 (2005) 509-521
33. Kushida T., Inaba M., Hisha H., Ichioka N., Esumi T., Ogawa R., Iida H., and Ikehara S. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97 (2001) 3292-3299
34. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., and Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59 (2002) 514-523
35. Lino M.M., Schneider C., and Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22 (2002) 4825-4832
36. Okabe M., Ikawa M., Kominami K., Nakanishi T., and Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407 (1997) 313-319
37. Rodríguez-Gómez J.A., Lu J.Q., Velasco I., Rivera S., Zoghbi S.S., Liow J.S., Musachio J.L., Chin F.T., Toyama H., Seidel J., Green M.V., Thanos P.K., Ichise M., Pike V.W., Innis R.B., and McKay R.D. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25 (2007) 918-928
38. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., and Brown Jr. H.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
39. Saccardi R., Mancardi G.L., Solari A., Bosi A., Bruzzi P., Di Bartolomeo P., Donelli A., Filippi M., Guerrasio A., Gualandi F., La Nasa G., Murialdo A., Pagliai F., Papineschi F., Scappini B., and Marmont A.M. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 105 (2005) 2601-2607
40. Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1046-1057
41. Solomon J.N., Lewis C.A., Ajami B., Corbel S.Y., Rossi F.M., and Krieger C. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia 53 (2006) 744-753
42. Strong M., and Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph. Lateral Scler. Other mot. Neuron Disord. 4 (2003) 136-143
43. Takeuchi K., Inaba M., Miyashima S., Ogawa R., and Ikehara S. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice. Blood 91 (1998) 4616-4623
44. Van Wijmeersch B., Sprangers B., Rutgeerts O., Lenaerts C., Landuyt W., Waer M., Billiau A.D., and Dubois B. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect. Biol. Blood Marrow Transplant. 13 (2007) 627-637
45. Wate R., Ito H., Zhang J.H., Ohnishi S., Nakano S., and Kusaka H. Expression of an endoplasmic reticulum-resident chaperone, glucose-regulated stress protein 78, in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. 110 (2005) 557-562
46. Willing A.E., Garbuzova-Davis S., Saporta S., Milliken M., Cahill D.W., and Sanberg P.R. hNT neurons delay onset of motor deficits in a model of amyotrophic lateral sclerosis. Brain Res. Bull. 56 (2001) 525-530
47. Xu L., Yan J., Chen D., Welsh A.M., Hazel T., Johe K., Hatfield G., and Koliatsos V.E. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 82 (2006) 865-875
48. Yamasaki T.R., Blurton-Jones M., Morrissette D.A., Kitazawa M., Oddo S., and LaFerla F.M. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J. Neurosci. 27 (2007) 11925-11933